UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023572
Receipt number R000027148
Scientific Title Impact of exercise training in combination with essential amino acid containing food on skeletal muscle volume and strength in patients with heart failure.
Date of disclosure of the study information 2016/08/20
Last modified on 2018/12/28 15:15:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of exercise training in combination with essential amino acid containing food on skeletal muscle volume and strength in patients with heart failure.

Acronym

CVI-ARO 11 study

Scientific Title

Impact of exercise training in combination with essential amino acid containing food on skeletal muscle volume and strength in patients with heart failure.

Scientific Title:Acronym

CVI-ARO 11 study

Region

Japan


Condition

Condition

Chronic heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to seek whether essentail amino-acid supplementation improves effectively the reduced skeletal muscle volume and strength in patients with heart failure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Thigh muscle volume and strength

Key secondary outcomes

BNP(brain natriuretic peptide), variables obtained by echocardiography, QOL, exercise capacity)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

taking essential amino acid containing food every day for 3 months and exercise training

Interventions/Control_2

exercise training only
;aerobic exercise and strength training
for 3 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

diagnosed as chronic heart failure
be able to take the food orally
be able to attend the supervised cardiac rehabilitation program at least once a week.

Key exclusion criteria

under hemodialysis
severe valvular stenosis
orthopedic disease which do not allow exercise training
food allergy especially for apple
already taking medicine containing BCAA

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuko Kato

Organization

The Cardiovascular Institute

Division name

Cardiovascular medicine

Zip code


Address

3-2-19, Nishiazabu, Minato-ku, Tokyo, Japan

TEL

0334082151

Email

kimuchi@nms.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazumi Matsuda

Organization

The Cardiovascular Institute

Division name

Office

Zip code


Address

0334082151

TEL

0334082151

Homepage URL


Email

matsuda@cvi.or.jp


Sponsor or person

Institute

CVI ARO

Institute

Department

Personal name



Funding Source

Organization

Ajinomoto CO., Inc

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete

2018 Year 06 Month 30 Day

Date analysis concluded

2018 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 09 Day

Last modified on

2018 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027148


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name